GSK plc Reports Share Transaction in 6-K Filing
Ticker: GSK · Form: 6-K · Filed: Apr 10, 2026 · CIK: 0001131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GSK) |
| Form Type | 6-K |
| Filed Date | Apr 10, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transaction, sec-filing, 6-k
TL;DR
GSK plc filed a 6-K on 4/10/26 about a share transaction.
AI Summary
On April 10, 2026, GSK plc filed a Form 6-K with the SEC, reporting a transaction involving its own shares. The filing details a transaction in its own shares, with the report period ending on the same date. The company's mailing and business address is 79 New Oxford Street, London, United Kingdom.
Why It Matters
This filing indicates GSK plc is actively managing its share capital, which could signal changes in its financial strategy or market presence.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a share transaction and does not contain information suggesting significant immediate risk.
Key Players & Entities
- GSK plc (company) — Filer of the 6-K report
- 0001131399 (company) — CIK number for GSK plc
- 2026-04-10 (date) — Filing date and period of report
- 79 New Oxford Street, London, United Kingdom (location) — Mailing and business address of GSK plc
FAQ
What type of transaction did GSK plc report on April 10, 2026?
GSK plc reported a 'TRANSACTION IN OWN SHARES' on April 10, 2026.
What is the CIK number for GSK plc?
The CIK number for GSK plc is 0001131399.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is April 10, 2026.
Where is GSK plc's business address listed in the filing?
GSK plc's business address is listed as 79 New Oxford Street, London, United Kingdom.
What is the accession number for this SEC filing?
The accession number for this SEC filing is 0001654954-26-003393.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2026 regarding GSK plc (GSK).